122 related articles for article (PubMed ID: 30641763)
1. Significance of glycated LDL in different stages of diabetic nephropathy.
Siddiqui K; George TP; Nawaz SS; Yaslam M; Almogbel E; Al-Rubeaan K
Diabetes Metab Syndr; 2019; 13(1):548-552. PubMed ID: 30641763
[TBL] [Abstract][Full Text] [Related]
2. Association between plasma oxidized low-density lipoprotein and diabetic nephropathy.
Ujihara N; Sakka Y; Takeda M; Hirayama M; Ishii A; Tomonaga O; Babazono T; Takahashi C; Yamashita K; Iwamoto Y
Diabetes Res Clin Pract; 2002 Nov; 58(2):109-14. PubMed ID: 12213352
[TBL] [Abstract][Full Text] [Related]
3. The changes in miR-130b levels in human serum and the correlation with the severity of diabetic nephropathy.
Lv C; Zhou YH; Wu C; Shao Y; Lu CL; Wang QY
Diabetes Metab Res Rev; 2015 Oct; 31(7):717-24. PubMed ID: 25952368
[TBL] [Abstract][Full Text] [Related]
4. Higher serum betatrophin level in type 2 diabetes subjects is associated with urinary albumin excretion and renal function.
Chen CC; Susanto H; Chuang WH; Liu TY; Wang CH
Cardiovasc Diabetol; 2016 Jan; 15():3. PubMed ID: 26739836
[TBL] [Abstract][Full Text] [Related]
5. Assessment of Vitamin D-Binding Protein and Early Prediction of Nephropathy in Type 2 Saudi Diabetic Patients.
Fawzy MS; Abu AlSel BT
J Diabetes Res; 2018; 2018():8517929. PubMed ID: 29850609
[TBL] [Abstract][Full Text] [Related]
6. High levels of AGE-LDL, and of IgG antibodies reacting with MDA-lysine epitopes expressed by oxLDL and MDA-LDL in circulating immune complexes predict macroalbuminuria in patients with type 2 diabetes.
Lopes-Virella MF; Hunt KJ; Baker NL; Virella G;
J Diabetes Complications; 2016; 30(4):693-9. PubMed ID: 26861948
[TBL] [Abstract][Full Text] [Related]
7. Oxidized LDL Is Associated with eGFR Decline in Proteinuric Diabetic Kidney Disease: A Cohort Study.
Roumeliotis S; Roumeliotis A; Georgianos PI; Stamou A; Manolopoulos VG; Panagoutsos S; Liakopoulos V
Oxid Med Cell Longev; 2021; 2021():2968869. PubMed ID: 34712380
[TBL] [Abstract][Full Text] [Related]
8. Expression Level of Circulating Cell Free miR-155 Gene in Serum of Patients with Diabetic Nephropathy.
Akhbari M; Khalili M; Shahrabi-Farahani M; Biglari A; Bandarian F
Clin Lab; 2019 Aug; 65(8):. PubMed ID: 31414764
[TBL] [Abstract][Full Text] [Related]
9. Circulating Fibroblast Growth Factors 21 and 23 as Biomarkers of Progression in Diabetic Nephropathy in Type 2 Diabetes with Normoalbuminuria.
El-Saeed AM; El-Mohasseb GF
Egypt J Immunol; 2017 Jun; 24(2):93-99. PubMed ID: 29528583
[TBL] [Abstract][Full Text] [Related]
10. The changes of serum sKlotho and NGAL levels and their correlation in type 2 diabetes mellitus patients with different stages of urinary albumin.
Wu C; Wang Q; Lv C; Qin N; Lei S; Yuan Q; Wang G
Diabetes Res Clin Pract; 2014 Nov; 106(2):343-50. PubMed ID: 25263500
[TBL] [Abstract][Full Text] [Related]
11. Atherogenic lipoprotein changes in diabetic nephropathy.
Shoji T; Emoto M; Kawagishi T; Kimoto E; Yamada A; Tabata T; Ishimura E; Inaba M; Okuno Y; Nishizawa Y
Atherosclerosis; 2001 Jun; 156(2):425-33. PubMed ID: 11395040
[TBL] [Abstract][Full Text] [Related]
12. Urinary platelet-derived growth factor-BB as an early marker of nephropathy in patients with type 2 diabetes: an Egyptian study.
Bessa SS; Hussein TA; Morad MA; Amer AM
Ren Fail; 2012; 34(6):670-5. PubMed ID: 22486214
[TBL] [Abstract][Full Text] [Related]
13. Association Between Matrix Metalloproteinase-3 Activity and Glomerular Filtration Rate and Albuminuria Status in Patients With Type 2 Diabetes Mellitus.
Amanzadeh M; Mota A; Zarghami N; Abedi-Azar S; Abroon S; Akbarian N; Mihanfar A; Rahmati-Yamchi M
Iran J Kidney Dis; 2018 Jan; 12(1):40-47. PubMed ID: 29421776
[TBL] [Abstract][Full Text] [Related]
14. High prevalence of small LDL particles in non-insulin-dependent diabetic patients with nephropathy.
Hirano T; Naito H; Kurokawa M; Ebara T; Nagano S; Adachi M; Yoshino G
Atherosclerosis; 1996 Jun; 123(1-2):57-72. PubMed ID: 8782837
[TBL] [Abstract][Full Text] [Related]
15. ApoM/HDL-C and apoM/apoA-I ratios are indicators of diabetic nephropathy in healthy controls and type 2 diabetes mellitus.
Zhang P; Gao J; Pu C; Feng G; Wang L; Huang L; Zhang Y
Clin Chim Acta; 2017 Mar; 466():31-37. PubMed ID: 28073663
[TBL] [Abstract][Full Text] [Related]
16. The Saudi Diabetic Kidney Disease study (Saudi-DKD): clinical characteristics and biochemical parameters.
Al-Rubeaan K; Siddiqui K; Alghonaim M; Youssef AM; AlNaqeb D
Ann Saudi Med; 2018; 38(1):46-56. PubMed ID: 29295969
[TBL] [Abstract][Full Text] [Related]
17. ALCAM a novel biomarker in patients with type 2 diabetes mellitus complicated with diabetic nephropathy.
Sulaj A; Kopf S; Gröne E; Gröne HJ; Hoffmann S; Schleicher E; Häring HU; Schwenger V; Herzig S; Fleming T; Nawroth PP; von Bauer R
J Diabetes Complications; 2017 Jun; 31(6):1058-1065. PubMed ID: 28325697
[TBL] [Abstract][Full Text] [Related]
18. Plasma Triglycerides and HDL-C Levels Predict the Development of Diabetic Kidney Disease in Subjects With Type 2 Diabetes: The AMD Annals Initiative.
Russo GT; De Cosmo S; Viazzi F; Pacilli A; Ceriello A; Genovese S; Guida P; Giorda C; Cucinotta D; Pontremoli R; Fioretto P;
Diabetes Care; 2016 Dec; 39(12):2278-2287. PubMed ID: 27703024
[TBL] [Abstract][Full Text] [Related]
19. E-cadherin and periostin in early detection and progression of diabetic nephropathy: epithelial-to-mesenchymal transition.
El-Dawla NMQ; Sallam AM; El-Hefnawy MH; El-Mesallamy HO
Clin Exp Nephrol; 2019 Aug; 23(8):1050-1057. PubMed ID: 31104272
[TBL] [Abstract][Full Text] [Related]
20. Growth arrest-specific protein 6 (Gas6) as a noninvasive biomarker for early detection of diabetic nephropathy.
Li W; Wang J; Ge L; Shan J; Zhang C; Liu J
Clin Exp Hypertens; 2017; 39(4):382-387. PubMed ID: 28513288
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
